Elevate Uranium Ltd

Elevate Uranium Ltd

0.20
AUD
+0.00
(-2.50%)
-0.04EPS
121.84MMarket Cap
Mar 11Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.36
-0.14
-0.09
-0.08
-0.06
-0.03
-0.02
-0.02
-0.01
-0.02
-0.03
-0.04
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.22
-0.19
-0.12
-0.08
-0.04
-0.02
0.01
0.03
0.04
0.07
0.04
0.04
- -
Tangible Book Value per Share
-0.22
-0.19
-0.12
-0.08
-0.04
-0.02
0.01
0.03
0.04
0.07
0.04
0.04
- -
Basic Weighted Avg Shares
7
10
14
17
30
48
69
103
181
252
276
295
354
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-1
-1
-1
-2
-1
-1
-2
-3
-6
-9
-11
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
-1
- -
- -
1
1
6
15
9
9
- -
LT Debt
2
2
2
2
2
2
- -
- -
- -
- -
- -
- -
- -
Total Equity
-2
-2
-2
-2
-2
-1
1
4
10
18
12
12
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
-74.91
-38.71
-40.9
-57.54
-92.3
- -

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.03
2024
- -
- -
-0.04
2025
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Murray Hill
Full Time Employees
20
Sector
Non-energy minerals
Industry
Other metals/Minerals
Address
5 Ord Street West Perth WA Australia 6005
IPO Date
Apr 8, 1983
Business
Elevate Uranium Ltd Elevate Uranium Ltd engages in the exploration, evaluation, and development of uranium deposits and other minerals, primarily in Namibia and Australia. The company holds a global mineral resource base of approximately 160.5 million pounds of U3O8, including its flagship Koppies Uranium Project in Namibia with 66.1 million pounds U3O8 (78% in the JORC Indicated category), the nearby Hirabeb deposit with a 10.2 million pounds U3O8 Maiden Inferred Resource, the 75%-owned Marenica Uranium Project with 61 million pounds U3O8 (Elevate's share 46 million pounds), and Australian assets such as the 100%-owned Angela Project with 31 million pounds U3O8 at 1,310 ppm, Thatcher Soak with 11 million pounds U3O8, and others including Minerva; it employs its proprietary, 100%-owned U-pgrade beneficiation process, which reduces ore mass by over 95% prior to leaching, boosting grades such as from 93 ppm to 5,000 ppm U3O8 at Marenica while cutting capital and operating costs by about 50% versus conventional methods, thereby enhancing project economics and development optionality. Headquartered in West Perth, Australia, Elevate Uranium Ltd maintains extensive tenements as Namibia's largest uranium holder and pursues active drilling programs totaling around 100,000 meters across its portfolio to expand resources. Recent developments include a strongly supported A$25 million institutional placement in October 2024, led by Paradice Investment Management with a A$12.4 million commitment for a 9.9% stake, to fund U-pgrade demonstration plant construction and operation by mid-2025 on Koppies ore, complete bench-scale metallurgical testwork, advance a Koppies scoping study, and support exploration drilling; an upgrade of the Koppies resource from inferred to indicated status in October 2024; divestment of the Oobagooma Uranium Project in Western Australia to Orpheus Uranium Ltd Orpheus Uranium Ltd in October 2025 for cash, shares, and milestone payments to sharpen focus on Namibian and Northern Territory assets; and ongoing high-impact drilling successes such as positive chemical assays confirming results at the Bigrlyi joint venture in December 2024 and high-grade intersections at Hirabeb in August 2024.